Amodex | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Amodex
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Amodex

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

107 API Suppliers, 40 USDMF, 30 CEP/COS, 5 JDMF, 2 EU WC, 37 KDMF, 21 NDC API, 4 VMF, 26 Listed Suppliers, $ API Reference Price

107 API Suppliers
40 USDMF
30 CEP/COS
5 JDMF
2 EU WC
37 KDMF
21 NDC API
4 VMF
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

126 Drugs in Development

126 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1500 FDF Dossiers, 208 FDA Orange Book, 570 Europe, 115 Canada, 71 Australia, 146 South Africa, 390 Listed Dossiers

1500 FDF Dossiers
208 FDA Orange Book
570 Europe
115 Canada
71 Australia
146 South Africa
390 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML, FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML, TABLET;ORAL - 875MG;EQ 125MG BASE, FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML, FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 400MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 775MG, CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML
FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML
TABLET;ORAL - 875MG;EQ 125MG BASE
FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML
FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML
CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 400MG/5ML
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 775MG
CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 1 Kirsch Pharma, 1 ACG Worldwide, 3 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 2 CD Formulation, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 1 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives, 22 Fillers, Diluents & Binders, 22 Thickeners and Stabilizers, 19 Controlled & Modified Release, 14 Disintegrants & Superdisintegrants, 11 Lubricants & Glidants, 10 Topical, 9 Granulation, 9 Direct Compression, 7 Rheology Modifiers, 7 Co-Processed Excipients, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Taste Masking, 5 Solubilizers, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Emulsifying Agents, 4 Chewable & Orodispersible Aids, 1 Parenteral

39 Coating Systems & Additives
22 Fillers, Diluents & Binders
22 Thickeners and Stabilizers
19 Controlled & Modified Release
14 Disintegrants & Superdisintegrants
11 Lubricants & Glidants
10 Topical
9 Granulation
9 Direct Compression
7 Rheology Modifiers
7 Co-Processed Excipients
6 Film Formers & Plasticizers
5 Empty Capsules
5 API Stability Enhancers
5 Taste Masking
5 Solubilizers
4 Vegetarian Capsules
4 Coloring Agents
4 Emulsifying Agents
4 Chewable & Orodispersible Aids
1 Parenteral

DIGITAL CONTENT

77 News #PharmaBuzz

77 News #PharmaBuzz

GLOBAL SALES INFORMATION

25 US Medicaid Prescriptions, 545 Regulatory FDF Prices, 11 Annual Reports

25 US Medicaid Prescriptions
545 Regulatory FDF Prices
11 Annual Reports

MARKET PLACE

105 APIs, 44 FDF Dossiers

105 APIs
44 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 6 US Exclusivities, 2 Health Canada Patents

14 US Patents
6 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 22 Others

3 EDQM
2 USP
22 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ API Ref.Price (USD/KG) : 32 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2GlaxoSmithKline Inc.

filter Patent Reset all filters

2 All

01 22220103

filter Product Reset all filters

2 All

01 2Amoxicillin | Clavulanic acid

filter Dosage Reset all filters

2 All

01 2Suspension

filter Exp Date Reset all filters

2 All

01 22016-05-02

Product Main Page

01

GlaxoSmithKline Inc.

Amoxicillin Trihydrate, Clavulanic Acid

CPhI Korea

Not Confirmed

GlaxoSmithKline Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-05-02

Date Granted : 2006-06-20

Amoxicillin Trihydrate, Clavulanic Acid

Brand Name : CLAVULIN

Patent Number : 2220103

Filing Date : 1996-05-02

Strength per Unit : 200mg/5mL amox, 28.5mg/5mL clavulanic

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-05-02

Date Granted : 2006-06-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Amoxicillin Trihydrate, Clavulanic Acid

CPhI Korea

Not Confirmed

GlaxoSmithKline Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-05-02

Date Granted : 2006-06-20

Amoxicillin Trihydrate, Clavulanic Acid

Brand Name : CLAVULIN

Patent Number : 2220103

Filing Date : 1996-05-02

Strength per Unit : 400mg / 5mL amox, 57mg / 5mL clavulanic

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-05-02

Date Granted : 2006-06-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!